A Multicenter, Open-Label, Non-Randomised First in Human Study of NG-350A in Patients with Metastatic or Advanced Epithelial Tumours (FORTITUDE)
This Study is
No Longer Enrolling
Details
Age
Adult
Eligibility
Disease must be epithelial ( carcinoma or adenocarcinoma )
Type of Study
Treatment
Locations
University of Colorado Hospital
Study ID
Protocol Number: 19-1147
More information available at ClinicalTrials.gov: NCT03852511
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers